Publication | Closed Access

A phase II study evaluating CAVi (cyclophosphamide, adriamycin, vincristine) potentiated or not by amphotericin B entrapped into sonicated liposomes, as salvage therapy for small cell lung cancer

NanotherapeuticsMedicinePharmacologyPhase Ii StudyAmphotericin BTumor TargetingAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyLung CancerSalvage Therapy